Literature DB >> 33479210

GATA2 regulates mast cell identity and responsiveness to antigenic stimulation by promoting chromatin remodeling at super-enhancers.

Yapeng Li1, Junfeng Gao1, Mohammad Kamran1, Laura Harmacek2, Thomas Danhorn2, Sonia M Leach1,2, Brian P O'Connor2, James R Hagman1,3, Hua Huang4,5.   

Abstract

Mast cells are critical effectors of allergic inflammation and protection against parasitic infections. We previously demonstrated that transcription factors GATA2 and MITF are the mast cell lineage-determining factors. However, it is unclear whether these lineage-determining factors regulate chromatin accessibility at mast cell enhancer regions. In this study, we demonstrate that GATA2 promotes chromatin accessibility at the super-enhancers of mast cell identity genes and primes both typical and super-enhancers at genes that respond to antigenic stimulation. We find that the number and densities of GATA2- but not MITF-bound sites at the super-enhancers are several folds higher than that at the typical enhancers. Our studies reveal that GATA2 promotes robust gene transcription to maintain mast cell identity and respond to antigenic stimulation by binding to super-enhancer regions with dense GATA2 binding sites available at key mast cell genes.

Entities:  

Year:  2021        PMID: 33479210      PMCID: PMC7820599          DOI: 10.1038/s41467-020-20766-0

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  73 in total

1.  Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation.

Authors:  F Y Tsai; S H Orkin
Journal:  Blood       Date:  1997-05-15       Impact factor: 22.113

2.  Mast cell FcεRI-induced early growth response 2 regulates CC chemokine ligand 1-dependent CD4+ T cell migration.

Authors:  Zhengli Wu; Adam J Macneil; Robert Junkins; Bo Li; Jason N Berman; Tong-Jun Lin
Journal:  J Immunol       Date:  2013-03-27       Impact factor: 5.422

3.  Characterization of HRG22, a human homologue of the putative tumor suppressor gene HIC1.

Authors:  S Deltour; S Pinte; C Guérardel; D Leprince
Journal:  Biochem Biophys Res Commun       Date:  2001-09-21       Impact factor: 3.575

4.  The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene.

Authors:  Benjamin D Rowland; René Bernards; Daniel S Peeper
Journal:  Nat Cell Biol       Date:  2005-11       Impact factor: 28.824

Review 5.  Melanocytes and the microphthalmia transcription factor network.

Authors:  Eiríkur Steingrímsson; Neal G Copeland; Nancy A Jenkins
Journal:  Annu Rev Genet       Date:  2004       Impact factor: 16.830

6.  Master transcription factors and mediator establish super-enhancers at key cell identity genes.

Authors:  Warren A Whyte; David A Orlando; Denes Hnisz; Brian J Abraham; Charles Y Lin; Michael H Kagey; Peter B Rahl; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

7.  Target analysis by integration of transcriptome and ChIP-seq data with BETA.

Authors:  Su Wang; Hanfei Sun; Jian Ma; Chongzhi Zang; Chenfei Wang; Juan Wang; Qianzi Tang; Clifford A Meyer; Yong Zhang; X Shirley Liu
Journal:  Nat Protoc       Date:  2013-11-21       Impact factor: 13.491

8.  GATA-2 regulates granulocyte-macrophage progenitor cell function.

Authors:  Neil P Rodrigues; Ashleigh S Boyd; Cristina Fugazza; Gillian E May; Yanping Guo; Alex J Tipping; David T Scadden; Paresh Vyas; Tariq Enver
Journal:  Blood       Date:  2008-10-07       Impact factor: 22.113

9.  SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene.

Authors:  Xin-Hua Cheng; Markaisa Black; Vladimir Ustiyan; Tien Le; Logan Fulford; Anusha Sridharan; Mario Medvedovic; Vladimir V Kalinichenko; Jeffrey A Whitsett; Tanya V Kalin
Journal:  PLoS Genet       Date:  2014-09-25       Impact factor: 5.917

10.  DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes.

Authors:  Si Ho Choi; Micah D Gearhart; Ziyou Cui; Darko Bosnakovski; Minjee Kim; Natalie Schennum; Michael Kyba
Journal:  Nucleic Acids Res       Date:  2016-03-06       Impact factor: 16.971

View more
  7 in total

1.  Single-cell multiomics analysis reveals regulatory programs in clear cell renal cell carcinoma.

Authors:  Zhilin Long; Chengfang Sun; Min Tang; Yin Wang; Jiayan Ma; Jichuan Yu; Jingchao Wei; Jianzhu Ma; Bohan Wang; Qi Xie; Jiaming Wen
Journal:  Cell Discov       Date:  2022-07-19       Impact factor: 38.079

2.  IL-3 Expands Pre-Basophil and Mast Cell Progenitors by Upregulating the IL-3 Receptor Expression.

Authors:  Yapeng Li; Xiaopeng Qi; Diazheng Zhao; Joseph F Urban; Hua Huang
Journal:  Cell Immunol       Date:  2022-03-06       Impact factor: 4.178

3.  Gata2 heterozygous mutant mice exhibit reduced inflammatory responses and impaired bacterial clearance.

Authors:  Jun Takai; Takashi Shimada; Tadaho Nakamura; James Douglas Engel; Takashi Moriguchi
Journal:  iScience       Date:  2021-07-29

Review 4.  Transcription Factors in the Development and Pro-Allergic Function of Mast Cells.

Authors:  Mansi Srivastava; Mark H Kaplan
Journal:  Front Allergy       Date:  2021-06-07

5.  Fetal sex-specific epigenetic associations with prenatal maternal depressive symptoms.

Authors:  Michelle Z L Kee; Ai Ling Teh; Andrew Clappison; Irina Pokhvisneva; Julie L MacIssac; David T S Lin; Katia E Ramadori; Birit F P Broekman; Helen Chen; Mary Lourdes Daniel; Neerja Karnani; Michael S Kobor; Peter D Gluckman; Yap Seng Chong; Jonathan Y Huang; Michael J Meaney
Journal:  iScience       Date:  2022-08-04

Review 6.  New Mechanistic Advances in FcεRI-Mast Cell-Mediated Allergic Signaling.

Authors:  Yang Li; Patrick S C Leung; M Eric Gershwin; Junmin Song
Journal:  Clin Rev Allergy Immunol       Date:  2022-10-17       Impact factor: 10.817

7.  Inhibition of c-Fos expression attenuates IgE-mediated mast cell activation and allergic inflammation by counteracting an inhibitory AP1/Egr1/IL-4 axis.

Authors:  Hui-Na Wang; Kunmei Ji; Li-Na Zhang; Chu-Chu Xie; Wei-Yong Li; Zhen-Fu Zhao; Jia-Jie Chen
Journal:  J Transl Med       Date:  2021-06-15       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.